Skip to content
TRENDING:
Donald Trump
Advertisement

Articles by Tom Howell Jr.

Yvette Pau, 56, receives the second dose of the Pfizer-BioNTech COVID-19 vaccine, in Gibraltar, Thursday, March 4, 2021. Gibraltar, a densely populated narrow peninsula at the mouth of the Mediterranean Sea, is emerging from a two-month lockdown with the help of a successful vaccination rollout. The British overseas territory is currently on track to complete by the end of March the vaccination of both its residents over age 16 and its vast imported workforce. But the recent easing of restrictions, in what authorities have christened “Operation Freedom,” leaves Gibraltar with the challenge of reopening to a globalized world with unequal access to coronavirus jabs. (AP Photo/Bernat Armangue) **FILE**

Gibraltar, Seychelles, Bhutan near widespread coronavirus immunity

Tiny Asian countries and the British territory Gibraltar are nearing widespread immunity against COVID-19 and are gaining a sense of normalcy, proving it pays to be small and have a steady supply of shots if you want to zip ahead in the global vaccination race.

April 25, 2021
A COVID-19 patient receives oxygen inside a car provided by a Gurdwara, a Sikh house of worship, in New Delhi, India, Saturday, April 24, 2021. Indias medical oxygen shortage has become so dire that this gurdwara began offering free breathing sessions with shared tanks to COVID-19 patients waiting for a hospital bed. They arrive in their cars, on foot or in three-wheeled taxis, desperate for a mask and tube attached to the precious oxygen tanks outside the gurdwara in a neighborhood outside New Delhi. (AP Photo/Altaf Qadri)

U.S. sending aid to India amid COVID-19 crisis

The U.S. is sending protective gear, therapeutic drugs and raw materials for vaccines to India as it battles a catastrophic wave of COVID-19 cases that is taxing its health system, depleting oxygen supplies and forcing cremation centers to operate around the clock.

April 25, 2021
Dr. Francis Collins, director of the National Institutes of Health, appears before a Senate Health, Education, Labor and Pensions Committee hearing to discuss vaccines and protecting public health during the coronavirus pandemic on Capitol Hill, Wednesday, Sept. 9, 2020, in Washington. (Michael Reynolds/Pool via AP) ** *FILE **

NIH chief: Resuming J&J vaccine without limits is ‘right decision’

National Institutes of Health Director Francis Collins on Sunday said federal regulators and advisers made the right call in resuming the Johnson & Johnson vaccine for everyone, saying its benefits in fighting COVID-19 outweigh the threat of rare blood clots seen in a handful of recipients.

April 25, 2021